π Simple Summary
Ergothioneine is a unique antioxidant that your body cannot make β you must get it from food, primarily mushrooms. Unlike most antioxidants that come and go, your body has a dedicated transporter protein (OCTN1) that actively pulls ergothioneine from your bloodstream and concentrates it in tissues under the most oxidative stress: your brain, liver, kidneys, and red blood cells. In 2026, a landmark multi-tissue metabolomics study found that five different longevity interventions β rapamycin, acarbose, caloric restriction, canagliflozin, and 17Ξ±-estradiol β all converge on ergothioneine metabolism across multiple tissues. Another 2026 study showed that higher ergothioneine metabolism predicts slower cognitive decline in older adults with Alzheimer’s amyloid pathology. Bruce Ames, one of the most influential biochemists of the last century, classified ergothioneine as a “longevity vitamin” β a nutrient whose deficiency may cause insidious, cumulative damage over decades. The evidence is compelling but mostly observational in humans β we don’t yet have randomized trials proving it extends human lifespan.
The detailed breakdown continues below for those who want the full science.
If you’ve ever wondered why mushrooms keep showing up in longevity research, the answer might be a single molecule. In 2026, researchers analyzing five of the most validated longevity interventions β from the drug rapamycin to simple caloric restriction β found something unexpected: they all converged on the same metabolic pathway. The molecule at the center? Ergothioneine. Bruce Ames called it a “longevity vitamin” years before this data existed. Now the metabolomics are catching up.
π‘ SILVER β Strong mechanistic + convergent evidence, limited human interventional data
βοΈ At a Glance: Pros & Cons
β οΈ We are researchers, not doctors. Nothing on this page is medical advice. Always consult your physician before starting any supplement.
β Pros
Dedicated transporter: Your body has a specific protein (OCTN1) that actively pulls ergothioneine from food and concentrates it where oxidative stress is highest β a strong evolutionary signal that it matters.
Multi-intervention convergence: A 2026 multi-tissue metabolomics study found five different longevity interventions (rapamycin, acarbose, caloric restriction, canagliflozin, 17Ξ±-estradiol) all altered ergothioneine metabolism β placing it at a metabolic intersection for anti-aging.
Brain aging protection: Higher ergothioneine metabolism predicted slower cognitive decline in older adults with Alzheimer’s amyloid pathology (2026, Free Radical Biology & Medicine).
Dietary safety: Found naturally in mushrooms and other foods. No toxicity at supplemental doses. Half-life of roughly 30 days means levels build steadily.
β Cons
No human longevity trials: The most exciting evidence β convergence across interventions, circadian and NAD+ preservation β is from mice and metabolomics. No randomized trial has tested whether ergothioneine extends human lifespan.
Levels decline with diet: You can’t make it, so intake depends on what you eat. Mushroom-poor diets mean lower ergothioneine levels, and levels drop further with age.
No established RDA: Optimal human dosing is unknown. Studies use anywhere from 5β30 mg/day, but the right dose for longevity is anyone’s guess.
Observational, not causal: Human data shows associations between ergothioneine levels and better health outcomes β but we can’t yet prove supplementation causes those outcomes.
What Is Ergothioneine?
Ergothioneine (pronounced er-go-THIGH-oh-neen) is a sulfur-containing amino acid with a structure unlike anything your body produces. It was discovered in 1909 in ergot fungus, but it’s found throughout nature β and almost exclusively in fungi and certain bacteria. Humans, plants, and animals cannot synthesize it.
What makes ergothioneine special is its unusual chemical structure: it exists primarily as a thione rather than a thiol (the form most sulfur antioxidants like glutathione take). This thione form makes it exceptionally stable β it doesn’t auto-oxidize in the presence of oxygen the way glutathione does. It’s a slow-and-steady antioxidant rather than a fast-reacting one.
Your body goes to unusual lengths to get ergothioneine. The OCTN1 transporter (also called SLC22A4) is a protein embedded in cell membranes that actively pulls ergothioneine from your bloodstream into tissues. This isn’t passive diffusion β your cells are spending energy to concentrate ergothioneine. Evolution doesn’t preserve energy-expensive transporters for molecules that don’t matter.
The highest concentrations in the human body are found in:
- Red blood cells (bone marrow produces them with high OCTN1)
- Liver
- Kidneys
- Brain (especially the substantia nigra, which degenerates in Parkinson’s)
- Eye lens and cornea
- Bone marrow
The richest dietary sources:
- King oyster mushrooms: ~150 mg per 100g dry weight (the highest known source)
- Shiitake mushrooms: ~80 mg per 100g dry weight
- Oyster mushrooms: ~60 mg per 100g dry weight
- Porcini mushrooms: ~50 mg per 100g dry weight
- Black beans, red beans, oat bran, garlic: Small amounts (~0.5β3 mg per 100g)
A typical Western diet provides roughly 1β5 mg/day of ergothioneine, mostly from mushrooms if you eat them. Vegetarians and people who eat mushrooms regularly have significantly higher blood levels.
How It Works: Why Aging Makes It Relevant
Ergothioneine operates through several mechanisms, each relevant to different aspects of aging:
1. Direct oxidant scavenging (but selective): Unlike broad-spectrum antioxidants that mop up everything (including beneficial oxidative signals), ergothioneine is selective. It preferentially neutralizes hydroxyl radicals, singlet oxygen, and peroxynitrite β the most damaging reactive species. It also chelates iron and copper, preventing them from generating free radicals through the Fenton reaction.
2. Protection of mitochondrial DNA: Ergothioneine accumulates in mitochondria β your cells’ energy factories β where it protects mitochondrial DNA from oxidative damage. Mitochondrial DNA has fewer repair mechanisms than nuclear DNA, making it especially vulnerable with age.
3. Circadian rhythm preservation: The 2026 study by researchers at Kyoto University (PMID 42442093) found that ergothioneine supplementation reversed age-related declines in circadian clock function. Aging weakens your internal clock β the 24-hour rhythm that governs sleep, metabolism, and repair. Ergothioneine preserved both circadian amplitude and NAD+ levels in aging cells, possibly by maintaining a key enzyme in the NAD+ salvage pathway.
4. Anti-inflammatory via NF-ΞΊB suppression: Like many longevity compounds, ergothioneine dampens NF-ΞΊB β the master inflammatory switch that drives “inflammaging,” the chronic low-grade inflammation of old age.
5. Protection against protein oxidation and glycation: Ergothioneine prevents oxidative damage to proteins and inhibits the formation of advanced glycation end-products (AGEs), which cross-link proteins and stiffen tissues with age.
The Longevity Connection
π₯ Evidence Tier: Multi-Intervention Convergence
The 2026 metabolomics landmark (PMID 42427596): This is the single most important paper for ergothioneine and longevity. Researchers at the University of Michigan (led by the Miller lab, which runs the NIA’s Interventions Testing Program) treated male UM-HET3 mice β the gold-standard genetically heterogeneous mouse model for aging studies β with five validated longevity interventions: rapamycin, acarbose, 17Ξ±-estradiol, canagliflozin, and caloric restriction.
They then performed metabolomics on seven tissues. The finding: across all five interventions, ergothioneine metabolism was one of the few metabolic signals that consistently changed. Using machine learning, they showed that metabolomic profiles could identify mice receiving a longevity intervention well before survival differences emerged. And models trained on four interventions could identify mice on the fifth, unseen intervention β meaning the metabolic signature was shared, not intervention-specific.
The interpretation: ergothioneine sits at a metabolic intersection point where multiple anti-aging interventions converge. It’s not that ergothioneine is the longevity mechanism β but that increased ergothioneine metabolism appears to be a common downstream effect of interventions that extend lifespan.
π₯ Evidence Tier: Brain Aging and Cognitive Resilience
Cognitive resilience in Alzheimer’s pathology (PMID 42349803): A 2026 Singaporean study followed 259 dementia-free older adults for up to 5 years. Researchers measured plasma ergothioneine (ET), its metabolite hercynine (HC), and calculated the HC:ET ratio as an index of ergothioneine metabolism. The key result: people with higher HC:ET ratios (indicating more active ergothioneine metabolism) showed attenuated cognitive decline despite having elevated p-Tau181 and p-Tau217 β blood biomarkers of Alzheimer’s amyloid pathology. In plain English: higher ergothioneine metabolism appeared to protect the brain against the cognitive effects of Alzheimer’s pathology.
A 2026 study in Nature Aging (PMID 42342913) examining the blood metabolome of brain health in midlife also identified ergothioneine as relevant to cognitive function, though as part of a broader metabolic signature rather than a standalone finding.
π₯ Evidence Tier: Cardiovascular Protection
Cardiac fibrosis attenuation (PMID 42457094): In hypertensive rats fed a high-fat diet, ergothioneine (50 mg/kg daily for 10 weeks) reduced cardiac fibrosis by suppressing SMAD-2, a key mediator of TGF-Ξ²-driven scar tissue formation in the heart. It also reduced fibrosis markers (hydroxyproline, Ξ±-SMA, galectin-3) while favoring MMP-2 over TIMP-2 β enzymes that break down excess collagen.
π₯ Evidence Tier: Circadian Rhythm and NAD+ Preservation
Clock gene preservation (PMID 42442093): Aging weakens circadian clocks β the amplitude flattens, period variability increases. The Kyoto University study found ergothioneine supplementation restored circadian amplitude in aging cells, alongside preserving NAD+ levels. The mechanism appears to involve NAMPT, a rate-limiting enzyme in the NAD+ salvage pathway that declines with age. By protecting NAMPT, ergothioneine may help maintain youthful NAD+ levels β the same NAD+ that NMN and NR supplements aim to boost.
π₯ Evidence Tier: Reproductive Aging
Ovarian reserve (PMID 42310611): A 2026 pilot study tested oral L-ergothioneine supplementation in women with suboptimal ovarian reserve. Results showed improvements in hormonal markers and clinical symptoms β preliminary but notable because ovarian aging is one of the earliest measurable forms of human aging.
Key Studies
| Study | Design | Key Finding |
|---|---|---|
| Miller Lab / bioRxiv (2026) β Multi-tissue metabolomics of 5 longevity interventions | Mouse: UM-HET3, 7 tissues, machine learning | Ergothioneine metabolism convergently altered across rapamycin, acarbose, CR, canagliflozin, and 17Ξ±-estradiol β a shared metabolic signature of longevity interventions. |
| Free Radical Biol Med (2026) β Ergothioneine metabolism & cognitive resilience | Human: 259 older adults, 5-year follow-up | Higher HC:ET ratio (ergothioneine metabolism) attenuated cognitive decline despite elevated Alzheimer’s amyloid biomarkers. |
| BBRC (2026) β Ergothioneine & circadian rhythms | Cell culture: aging model | Ergothioneine restored circadian amplitude and preserved NAD+ levels in aging cells via NAMPT protection. |
| J Nutr Biochem (2026) β Ergothioneine & cardiac fibrosis | Rat: hypertensive + high-fat diet, 50 mg/kg Γ 10 weeks | Reduced cardiac fibrosis via SMAD-2 suppression; shifted MMP/TIMP balance toward collagen breakdown. |
| Nature Aging (2026) β Blood metabolome of brain health | Human: midlife metabolomics | Ergothioneine identified as part of the metabolic signature associated with brain health at midlife. |
| BMC Women’s Health (2026) β Ovarian reserve pilot | Human: open-label pilot, suboptimal ovarian reserve | Oral L-ergothioneine showed preliminary improvements in ovarian reserve markers and clinical symptoms. |
Dosing and Safety
Recommended Protocol (Based on Available Evidence)
| Parameter | Recommendation |
|---|---|
| Daily dose | 5β30 mg/day L-ergothioneine. Start at 5 mg, titrate up to 30 mg. |
| Form | L-(+)-Ergothioneine (the biologically active form). Synthetic or mushroom-derived β both are chemically identical. |
| Timing | With or without food. Take consistently β half-life is ~30 days, so daily dosing builds steady state levels. |
| Loading | Not needed. Blood levels rise over weeks. Aim for consistency, not speed. |
| Food source alternative | 100g fresh mushrooms (especially king oyster, shiitake) provides ~5-10 mg. Eating mushrooms 3β5 times per week may match supplemental intake. |
Safety Profile
| Side Effect | Frequency | Notes |
|---|---|---|
| None reported | Common | Most clinical trials report ergothioneine as well-tolerated with no serious adverse events. |
| Mild GI discomfort | Rare | Occasional reports at higher doses (>30 mg). Usually resolves with food. |
| Trimethylamine (TMA) production | Theoretical | One 2026 study (PMID 42510550) questioned whether ergothioneine could contribute to plasma TMA β which gets converted to TMAO, a cardiovascular risk marker. The evidence is preliminary and not cause for alarm, but worth monitoring as research evolves. |
β Common Questions About Ergothioneine
What is ergothioneine and how does it work?
Ergothioneine is a unique sulfur-containing antioxidant found almost exclusively in mushrooms. Your body cannot make it β you must get it from food. Unlike most antioxidants, your body has a dedicated transporter protein (OCTN1) that actively pulls it into tissues under high oxidative stress, including your brain, liver, and kidneys. It works by neutralizing the most damaging free radicals, protecting mitochondrial DNA, and preserving NAD+ levels as you age.
What does the evidence actually show?
The strongest evidence comes from a 2026 metabolomics study showing that five different longevity interventions β rapamycin, acarbose, caloric restriction, canagliflozin, and 17Ξ±-estradiol β all converged on ergothioneine metabolism in mice. In humans, higher ergothioneine metabolism predicted slower cognitive decline in older adults with Alzheimer’s amyloid pathology. Other studies show it preserves circadian rhythms and NAD+ levels. However, no randomized clinical trials have yet tested whether ergothioneine supplements extend human lifespan β the evidence is strong at the mechanistic level but observational in humans.
What’s the right dose?
Human studies typically use 5β30 mg per day of L-ergothioneine. There is no established RDA. Start at 5 mg daily β you can also get this from eating mushrooms regularly (3β5 servings per week of king oyster, shiitake, or oyster mushrooms). Ergothioneine has a long half-life of about 30 days, so daily consistency matters more than the exact dose. No loading phase is needed.
What are the risks and side effects?
Ergothioneine has an excellent safety record. Clinical trials report no serious adverse events, and it’s been consumed in mushrooms for thousands of years. The most significant theoretical concern β flagged in a 2026 study β is whether gut bacteria can convert ergothioneine to trimethylamine (TMA), which gets processed into TMAO, a cardiovascular risk marker. This is preliminary and hasn’t been shown to be a problem at normal doses, but it’s worth watching as research evolves. Mild GI discomfort has been reported rarely at higher doses.
Who should avoid it?
Pregnant and breastfeeding women should avoid ergothioneine supplements due to the lack of safety data in these populations (though dietary mushroom intake is fine). People with rare genetic variants affecting the OCTN1 transporter may not benefit from supplementation β this is uncommon but worth noting. Otherwise, ergothioneine appears safe for most adults. As always, anyone taking medications or managing a chronic condition should consult their doctor before adding any new supplement.
The Bottom Line
Evidence strength: Silver tier π‘. Mechanistic evidence for ergothioneine’s role in aging is unusually strong for a micronutrient β a dedicated transporter preserved across evolution, convergence of five longevity interventions on its metabolism, protection of NAD+ and circadian rhythms, and human data linking metabolism to cognitive resilience. What’s missing are human interventional trials showing supplementation extends lifespan or healthspan.
Our verdict: Among dietary antioxidants, ergothioneine has the strongest case for being genuinely important for aging β stronger than resveratrol, stronger than most polyphenols. The dedicated transporter is the key signal. Your body doesn’t waste energy concentrating molecules that don’t matter.
Cost-effectiveness: Eating mushrooms (especially king oyster, shiitake, and oyster) 3β5 times per week is the cheapest and safest way to boost ergothioneine. This also provides fiber, B vitamins, and other beneficial compounds. Supplements are available (typically $15β35/month for 5β30 mg/day) and may be worth considering if you don’t eat mushrooms regularly.
Who should consider it: People with low mushroom intake, those concerned about cognitive aging (given the Alzheimer’s resilience data), and anyone following longevity protocols who wants to cover their nutritional bases. Ergothioneine fits the Bruce Ames “longevity vitamin” framework β it’s a nutrient where chronic insufficiency may cause damage that only becomes apparent decades later.
Medical Disclaimer: This information is for educational purposes only. It is not medical advice and is not intended to diagnose, treat, cure, or prevent any disease. Ergothioneine is a dietary compound, not an FDA-approved drug. Always consult your physician before taking any supplement, especially if you are pregnant, nursing, taking medications, or managing a health condition.
Sources
- Miller RA et al. “Multi-Tissue Metabolomic Signatures of Five Longevity Interventions Converge on Ergothioneine and Lipid Remodeling in Male UM-HET3 Mice.” bioRxiv (2026). PMID: 42427596.
- Kyoto University researchers. “Ergothioneine attenuates age-related declines in circadian rhythmicity.” Biochem Biophys Res Commun (2026). PMID: 42442093.
- Singapore aging study. “Metabolism of the antioxidant micronutrient ergothioneine as a plasma biomarker of cognitive resilience in older people with Alzheimer’s disease amyloid pathology.” Free Radic Biol Med (2026). PMID: 42349803.
- Cardiac fibrosis study. “Ergothioneine attenuates cardiac fibrosis induced by a high-fat diet in spontaneously hypertensive rats.” J Nutr Biochem (2026). PMID: 42457094.
- Nature Aging brain metabolome study. “The blood metabolome of brain health in midlife and influences of genes, microbiome and exposome.” Nat Aging (2026). PMID: 42342913.
- Ovarian reserve pilot study. “Oral L-ergothioneine supplementation in women with suboptimal ovarian reserve.” BMC Womens Health (2026). PMID: 42310611.
- Comprehensive review. “Ergothioneine: An updated review on preparation strategies, biological activity and mechanisms, health and functional applications.” Food Chem (2026). PMID: 42288079.
- Topical ergothioneine study. “Unveiling and Benefits of Topically Applied L-(+)-Ergothioneine in Periwound Region.” Int J Mol Sci (2026). PMID: 42511449.
- PROMETHEUS clinical trial protocol. “PROMETHEUS clinical trial protocol: tailoring healthy ageing with lifestyle and nutraceuticals.” GeroScience (2026). PMID: 42393428.